Literature DB >> 21711991

Cognitive disturbance comparison among drug-naïve depressed cases and healthy controls.

M Iqbal Afridi1, Mehwish Hina, Imran Samad Qureshi, Musarrat Hussain.   

Abstract

OBJECTIVE: To assess and compare cognitive disturbances among newly diagnosed depressed and healthy control cases on the McNair and Kahn auto-evaluation scale. STUDY
DESIGN: Comparative, cross-sectional study. PLACE AND DURATION OF STUDY: Out-patients Department of Psychiatry, Jinnah Postgraduate Medical Centre, Karachi, Pakistan, from February to May, 2007.
METHODOLOGY: All consecutive new cases reporting at the out patient department were screened for depressive illness. They were matched with healthy-controls aged between 18-40 years. Clinical assessment was carried out on the basis of detailed history, physical examination, mental state examination by psychiatrists. For diagnostic purpose, application of ICD-10 followed by administration of Scale for Cognitive Difficulties.
RESULTS: Sixty subjects, 30 depressed patients (20 females and 10 males) and 30 healthy-controls (18 females and 12 males) were assessed. The age of cases with depressive disorder ranged 18-38 years. It was found that 63.3% (65% females and 60% males) depressed patients had cognitive difficulties compared to 3.3% of healthy-controls (p < 0.001). Proportions were compared using chi-square test with significance at p < 0.05.
CONCLUSION: Depression is not merely an emotional (mood) disorder but has an impact on cognition domain as well. Attention/concentration was the most common domain of cognition affected, followed by memory disturbance among the drug-naïve depressed patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21711991     DOI: 07.2011/JCPSP.351355

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  12 in total

1.  Late life depressive symptoms and cognitive function among older Mexican adults: the past and the present.

Authors:  Joseph L Saenz; Marc A Garcia; Brian Downer
Journal:  Aging Ment Health       Date:  2018-12-27       Impact factor: 3.658

2.  Impact of Education on Memory Deficits in Subclinical Depression.

Authors:  Molly E McLaren; Sarah M Szymkowicz; Joshua W Kirton; Vonetta M Dotson
Journal:  Arch Clin Neuropsychol       Date:  2015-06-23       Impact factor: 2.813

3.  Cognitive Impairments in First-Episode Drug-Naïve Versus Medicated Depressive Patients: RBANS in a Chinese Population.

Authors:  Qiu Fang Jia; Peng Chen; Hong Liang Zhu; Shan Shan Chen; Xiao Chu Gu; Xu Yuan Yin; Yan Hai Wu; Guang Zhong Yin; Li Hui
Journal:  Psychiatr Q       Date:  2019-09

4.  Association between Frequency of Conversations and Suicidal Ideation among Medical Students during COVID-19 Pandemic in Japan.

Authors:  Juri Yamazaki; Masashi Kizuki; Takeo Fujiwara
Journal:  Int J Environ Res Public Health       Date:  2022-05-24       Impact factor: 4.614

5.  Combined corticosterone treatment and chronic restraint stress lead to depression associated with early cognitive deficits in mice.

Authors:  Gwladys Temkou Ngoupaye; Francis Bray Yassi; Doriane Amanda Nguepi Bahane; Elisabeth Ngo Bum
Journal:  Metab Brain Dis       Date:  2017-12-03       Impact factor: 3.584

6.  Cognitive performance in antidepressant-free recurrent major depressive disorder.

Authors:  Kimberly M Albert; Guy G Potter; Douglas R McQuoid; Warren D Taylor
Journal:  Depress Anxiety       Date:  2018-04-10       Impact factor: 6.505

7.  A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.

Authors:  Atul R Mahableshwarkar; John Zajecka; William Jacobson; Yinzhong Chen; Richard S E Keefe
Journal:  Neuropsychopharmacology       Date:  2015-02-17       Impact factor: 7.853

8.  Defining cognitive profiles of depressive patients using the Brief Assessment of Cognition in Affective Disorders.

Authors:  Ruei-An Chen; Chun-Yi Lee; Yu Lee; Chi-Fa Hung; Yu-Chi Huang; Pao-Yen Lin; Sheng-Yu Lee; Liang-Jen Wang
Journal:  PeerJ       Date:  2019-08-01       Impact factor: 2.984

9.  Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study.

Authors:  Seung-Hoon Lee; Sang Won Jeon; Cheolmin Shin; Chi-Un Pae; Ashwin A Patkar; Prakash S Masand; Hyonggin An; Changsu Han
Journal:  Psychiatry Investig       Date:  2022-04-22       Impact factor: 3.202

10.  Effects of SSRI Antidepressants on Attentional Bias toward Emotional Scenes in First-Episode Depressive Patients: Evidence from an Eye-Tracking Study.

Authors:  Lei Zhang; Fengqiong Yu; Qian Hu; Yuxi Qiao; Rongrong Xuan; Gongjun Ji; Chunyan Zhu; Chunlan Cai; Kai Wang
Journal:  Psychiatry Investig       Date:  2020-09-17       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.